{"meta":{"query_hash":"592b5e7f5b1c","filters":{"venue":"Current Drug Targets - Infectious Disorders"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/592b5e7f5b1c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Drug+Targets+-+Infectious+Disorders"},"results":[{"id":"W2000122784","doi":"10.2174/1568005053174609","title":"Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic","funders":"","keywords":"Cyclin-dependent kinase; Biology; Antiviral drug; Viral replication; Kinase; Virology; Drug discovery; Drug resistance; Virus; Cancer; Bioinformatics; Cell cycle; Cell biology; Genetics","score_opus":0.023726204393084132,"score_gpt":0.35447768967265625,"score_spread":0.3307514852795721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000122784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0082936855,0.9677554,0.008664001,0.0032915869,0.0007811299,0.000059290072,0.00010717713,0.0000968105,0.0109509025],"genre_scores_gemma":[0.058323804,0.9223046,0.010766267,0.0019639167,0.00093353447,0.000098593984,0.0002850412,0.000027513095,0.0052966923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966764,0.000077167024,0.000028017908,0.00007523926,0.00009532873,0.00005666319],"domain_scores_gemma":[0.9996333,0.00013911168,0.00004353717,0.000023853943,0.00010598179,0.000054258893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097511295,0.0007642574,0.0009462427,0.0010893978,0.00028998108,0.0010893802,0.000533845,0.0008108778,0.0024954916],"category_scores_gemma":[0.0005746344,0.00031711522,0.0007762556,0.0007728603,0.00058943377,0.0015387023,0.00078375574,0.002838694,0.0011781277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073560467,0.00056076335,0.0012748087,0.007263565,0.00015650937,0.00062834326,0.00026636475,0.0020411727,0.08423444,0.044421468,0.022975484,0.8354415],"study_design_scores_gemma":[0.00019735572,0.0011637454,0.0020100395,0.00066429836,0.000276615,0.001452396,0.00010516978,0.0024074789,0.041143626,0.010583339,0.9399298,0.00006613104],"about_ca_topic_score_codex":0.00058996544,"about_ca_topic_score_gemma":0.0010639532,"teacher_disagreement_score":0.0024954916,"about_ca_system_score_codex":0.00093084364,"about_ca_system_score_gemma":0.0007762563,"threshold_uncertainty_score":0.008348286},"labels":[],"label_agreement":null},{"id":"W2052987107","doi":"10.2174/1568005014606143","title":"Lipopolysaccharide as a Target for the Development of Novel Therapeutics in Gram-Negative Bacteria","year":2001,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Lipopolysaccharide; Gram-negative bacteria; Lipid A; Bacteria; Biosynthesis; Function (biology); In vitro; Computational biology; Biology; Chemistry; Biochemistry; Microbiology; Cell biology; Escherichia coli; Immunology; Enzyme; Genetics","score_opus":0.03574007799130596,"score_gpt":0.3414995194850012,"score_spread":0.3057594414936952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052987107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009868592,0.9940187,0.00077641,0.00046590617,0.00033846992,0.000012883462,0.000020830712,0.000020232299,0.0033596775],"genre_scores_gemma":[0.0036241077,0.99145764,0.0010525248,0.00027950478,0.00017502575,0.00001855443,0.00004938754,0.0000032260573,0.0033400364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991,0.000017593864,0.000009079133,0.000014119551,0.00003951875,0.000009611917],"domain_scores_gemma":[0.99993455,0.00001926673,0.00000940954,0.0000033242702,0.000020789155,0.000012695074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028825886,0.0005965886,0.0008443149,0.000957887,0.00027295496,0.0006834731,0.0004594112,0.00088259083,0.003773063],"category_scores_gemma":[0.00018685666,0.00014890336,0.00021430705,0.0009545657,0.0002851091,0.000940085,0.00032400218,0.0008835719,0.003999731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017847039,0.00016457104,0.00022571554,0.008406192,0.00004594374,0.00087628706,0.0000962771,0.0005711014,0.031200262,0.008601761,0.019257918,0.93037564],"study_design_scores_gemma":[0.00003816443,0.00026538424,0.0007591327,0.0011698348,0.00005489241,0.0029083039,0.0000777632,0.0001905414,0.005493764,0.002834646,0.9861921,0.00001553183],"about_ca_topic_score_codex":0.00034393716,"about_ca_topic_score_gemma":0.0006337019,"teacher_disagreement_score":0.003773063,"about_ca_system_score_codex":0.00045523018,"about_ca_system_score_gemma":0.00054479484,"threshold_uncertainty_score":0.012622178},"labels":[],"label_agreement":null},{"id":"W2081852455","doi":"10.2174/1568005023342362","title":"Strategic Targeting of Essential Host-pathogen Interactions in Chlamydial Disease","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Chlamydiae; Biology; Intracellular parasite; Pathogen; Chlamydia; Virulence; Microbiology; Chlamydia trachomatis; Human pathogen; Intracellular; Virology; Immunology; Bacteria; Gene; Genetics","score_opus":0.04407964193876839,"score_gpt":0.35716129643002725,"score_spread":0.31308165449125885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081852455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012193589,0.99403054,0.0008287367,0.00034845644,0.00020597827,0.000013156002,0.000015468435,0.00002209701,0.0033161738],"genre_scores_gemma":[0.006336432,0.98924935,0.0011873227,0.00025493553,0.00010902027,0.000020049458,0.000029145984,0.0000034510113,0.0028102759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999877,0.000030470215,0.000012799495,0.000016511447,0.000047146274,0.000016076625],"domain_scores_gemma":[0.9999229,0.000027704373,0.000010411258,0.0000044335916,0.000021445572,0.000013208833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039877396,0.0006434461,0.000867449,0.00091234554,0.00030897133,0.0006594449,0.0005651378,0.0010153668,0.00231326],"category_scores_gemma":[0.00024082373,0.00019738027,0.00020964828,0.0009198403,0.0003599699,0.0008031601,0.00033146597,0.00073568604,0.0018763482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017687897,0.00014578809,0.0003080159,0.006489538,0.000036225138,0.0006786309,0.00007707971,0.0006054368,0.023778953,0.006810554,0.010906113,0.94998676],"study_design_scores_gemma":[0.000061367035,0.00045767552,0.00174968,0.0010990852,0.00006456202,0.0037735486,0.00010061212,0.00020379483,0.010156262,0.0029118664,0.97940135,0.000020145118],"about_ca_topic_score_codex":0.00062038895,"about_ca_topic_score_gemma":0.0012836776,"teacher_disagreement_score":0.00231326,"about_ca_system_score_codex":0.0006305177,"about_ca_system_score_gemma":0.000643036,"threshold_uncertainty_score":0.0077385902},"labels":[],"label_agreement":null},{"id":"W2082634748","doi":"10.2174/1568005014606017","title":"History of Vaccines and Positioning of Current Trends","year":2001,"lang":"en","type":"article","venue":"Current Drug Targets - Infectious Disorders","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Medicines Canada","funders":"","keywords":"Milestone; Civilization; Infectious disease (medical specialty); Medicine; Virology; Disease; Political science; History; Pathology","score_opus":0.01811441038436491,"score_gpt":0.2885642788367619,"score_spread":0.270449868452397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082634748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048645316,0.75551546,0.0027389936,0.17811035,0.009127554,0.000058795722,0.00022092757,0.0000655346,0.0492979],"genre_scores_gemma":[0.083686545,0.8405284,0.0047097006,0.042573396,0.014811318,0.00013330216,0.00030498015,0.00008346635,0.013168918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946497,0.0026612084,0.00062573986,0.0005113285,0.0012468189,0.00030528512],"domain_scores_gemma":[0.98046345,0.011386646,0.0012470649,0.0007128958,0.004461608,0.0017283461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014698488,0.0005205237,0.0007714108,0.0029211114,0.0013447419,0.006201739,0.0009777099,0.0027932834,0.006755937],"category_scores_gemma":[0.020644056,0.00033389832,0.00028954845,0.0036401176,0.0049655167,0.0072786715,0.0018755659,0.005200255,0.0015470299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062474655,0.00019545676,0.0049051326,0.0043337806,0.00007343391,0.00037980548,0.0017885347,0.0007056035,0.0012307692,0.22245239,0.08593446,0.6773759],"study_design_scores_gemma":[0.000022183945,0.00022321622,0.002248435,0.0022224688,0.000030902393,0.0003129442,0.0007383772,0.000113254006,0.00053173734,0.028764589,0.96476525,0.000026650912],"about_ca_topic_score_codex":0.0025478667,"about_ca_topic_score_gemma":0.002365972,"teacher_disagreement_score":0.014698488,"about_ca_system_score_codex":0.005364698,"about_ca_system_score_gemma":0.0050347303,"threshold_uncertainty_score":0.07773399},"labels":[],"label_agreement":null},{"id":"W2166290770","doi":"10.2174/1568005024605855","title":"Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - Infectious Disorders","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":368,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Canada Research Chairs; Cystic Fibrosis Foundation","keywords":"Antimicrobial; Antibiotics; Antimicrobial peptides; Cationic polymerization; Biology; Microbiology; Computational biology; Chemistry; Organic chemistry","score_opus":0.03686783319529565,"score_gpt":0.32702904801601973,"score_spread":0.2901612148207241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166290770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016458606,0.9922593,0.0012651504,0.00072454027,0.00029068373,0.000024856468,0.000016175074,0.000031925592,0.003741511],"genre_scores_gemma":[0.009221815,0.9844557,0.0018139444,0.0007352001,0.00038210273,0.000041146766,0.000051360472,0.000005888942,0.0032928118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997787,0.000038873888,0.00002222,0.000031111005,0.0001032567,0.000025943102],"domain_scores_gemma":[0.99982977,0.000055274366,0.000024394998,0.000007408009,0.000046979734,0.000036067708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619773,0.0005871209,0.000738588,0.0013522428,0.00018306733,0.00091851776,0.0006486375,0.000946369,0.0026663737],"category_scores_gemma":[0.0004897749,0.00020844638,0.00022828304,0.000774909,0.00041698574,0.0009774575,0.00048333168,0.0011125761,0.002367181],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015117988,0.00019112768,0.00025906524,0.003272191,0.000028891265,0.00046885965,0.0000853344,0.00040900262,0.012326723,0.004658141,0.0117371185,0.9664125],"study_design_scores_gemma":[0.000105046805,0.00054645294,0.00078405056,0.0009021127,0.000026916292,0.0027049654,0.0000589768,0.00018823738,0.0057913964,0.0020683545,0.98680764,0.000015922056],"about_ca_topic_score_codex":0.00021432688,"about_ca_topic_score_gemma":0.0004320341,"teacher_disagreement_score":0.0026663737,"about_ca_system_score_codex":0.00053024234,"about_ca_system_score_gemma":0.00057275454,"threshold_uncertainty_score":0.008919954},"labels":[],"label_agreement":null}]}